Bing Li

6PUBLICATIONS
8CO-AUTHORS
Cancer geneticsMedical infection agents (incl. prions)Traditional Chinese medicine and treatmentsMolecular medicineRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 26, 2026
Annexin A2 Is Associated with Dietary Cholesterol-Induced Metabolic Dysregulation and the Progression of Hepatic Fibrosis.

|Mar 28, 2026
Loss of miR-146a induces cardiomyocyte proliferation after myocardial infarction through targeting Kctd15.

Chenrui Zhang, Xuejiao Wei, Yongqin He

|Dec 23, 2025
Network Pharmacology and Experimental Validation to Identify Potential Key Compounds of Danhong Injection in the Treatment of Myocardial Infarction.

Chenrui Zhang, Yongqin He, Xuejiao Wei

|Mar 18, 2025
Ginsenoside Rh2 Ameliorates Myocardial Infarction by Regulating Cardiomyocyte Pyroptosis Based on Network Pharmacology, Molecular Docking, and Experimental Verification.

Bing Li, Shuanglong Mou, Chenrui Zhang

|Oct 21, 2024
Exploring the mechanism of Danggui Sini Decoction in the treatment of myocardial infarction: A systematic review, network pharmacology, and molecular docking.

Zhenzhen Li, Shuang Liu, Rui Zhang

|Jan 28, 2024
MiR-431 promotes cardiomyocyte proliferation by targeting FBXO32 expression.

Mengsha Li, Chenrui Zhang, Lirong Tan

Pageof 1

Frequent Collaborators

3 joint publications

Chenrui Zhang

2 joint publications

Shuanglong Mou

2 joint publications

Xingwei Hu

2 joint publications

Mengsha Li